A5067461904- Aortic aneurysm repair treatments
- Aortic Disease and Treatment Approaches
- Infectious Aortic and Vascular Conditions
- Cardiac, Anesthesia and Surgical Outcomes
- Venous Thromboembolism Diagnosis and Management
- Vascular Procedures and Complications
- Cardiac Valve Diseases and Treatments
- Diagnosis and Treatment of Venous Diseases
- Peripheral Artery Disease Management
- Central Venous Catheters and Hemodialysis
- COVID-19 and healthcare impacts
- Infective Endocarditis Diagnosis and Management
- Vascular anomalies and interventions
- Abdominal vascular conditions and treatments
- Renal and Vascular Pathologies
- Cardiac Structural Anomalies and Repair
- COVID-19 Clinical Research Studies
- Trauma Management and Diagnosis
- Trauma and Emergency Care Studies
- Cardiac tumors and thrombi
- Case Reports on Hematomas
- Vascular Anomalies and Treatments
- Tracheal and airway disorders
- Atrial Fibrillation Management and Outcomes
- Orthopedic Infections and Treatments
University of Milan
2013-2025
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2019-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2021-2024
Ospedale Maggiore
2021-2024
University Medical Center Hamburg-Eppendorf
2023
Universität Hamburg
2023
IRCCS Policlinico San Donato
2013-2019
University of Insubria
2005-2011
Center for Vascular Biology Research
2006
Fondazione Audiologica Varese
2005
Endovascular treatment is not recommended for aortic pathologies in patients with connective tissue diseases (CTDs) other than redo operations and as bridging procedures emergencies. However, recent developments endovascular technology may challenge this dogma.
Graphical AbstractGraphical abstract addressing the gender gap in infrarenal abdominal aneurysm repair: women-specific insights and strategies to bridge disparities.Open new tabDownload slide
<title>Abstract</title> Tissue-level phase transitions are emerging as a crucial mechanism in tumour development and metastasis. This study aims to identify molecular determinants physical conditions that control active wetting solid-to-fluid transition of epithelial tissues. We focused on IRSp53, protein linking plasma membranes the cytoskeleton. Depleting MCF10 DCIS.com cells, disrupts coordinated collective movement by promoting local fluctuations cell velocity resulting increased tissue...
Purpose: The Manta Vascular Closure Device is a novel collagen-based vascular closure device that has been designed specifically for of large-bore percutaneous arterial accesses. aim this retrospective study to evaluate the immediate and 30-day outcome at completion endovascular aneurysm repair (EVAR) or thoracic aortic (TEVAR). hypothesis not inferior in obtaining hemostasis compared with Perclose ProGlide Suture-Mediated System device. Materials Methods: We recruited all accesses (T)EVAR...
To update our experience with thoracic aortic stent-graft treatment over a 5-year period, special consideration for the occurrence and management of complications.From December 2000 to June 2006, 52 patients pathologies underwent endovascular repair; there were 43 males (83%) 9 females, mean age 63 +/- 19 years (range 17-87). Fourteen (27%) treated degenerative aneurysm, 12 (24%) penetrating ulcer, 8 (15%) blunt traumatic injury, 7 (13%) acute type B dissection, 6 (11%) dissecting aneurysm;...
Acute renal artery occlusion is a rare but threatening problem; optimal therapeutic treatment remains challenge, and ultimate outcomes are still to be defined. In the last decades, several reports or short-case experiences have been reported describing use of selective infusion lytic agents into treat acute occlusion. We report 4 cases treated by catheter-directed intraarterial thrombolysis.